Strain Profile
Save
Limosilactobacillus reuteri ATCC 55730
◔
Human-origin
Where this strain was first isolated, curated from the literature and culture-collection catalogs. It describes provenance only — not suitability, and not benefit.
How we classify this →
Sequenced
Whether a public genome assembly is linked for this strain. Without one the genome screens cannot run. It is not a verdict on the organism.
How we classify this →
Public genome assembly available
Limosilactobacillus reuteri ATCC 55730 (the parent strain from which DSM 17938 was derived) has been evaluated in several randomized controlled trials, predominantly in pediatric populations, examining acute gastroenteritis in children. A separate RCT examined its use as an adjunct in pediatric distal ulcerative colitis. In vitro studies have examined activity against cariogenic bacteria such as Streptococcus mutans and periodontal pathogens, with a clinical lozenges trial examining oral health outcomes. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 63 body-system-tagged papers that concern each system. Research coverage, not measured effect.
+2 more systems
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 35 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
102 papers reference this strain in the probiotic database.
Match confidence
How strongly this paper was matched to this strain when the corpus was linked. It orders the list — it says nothing about the study's quality or its findings.
How we classify this →
2024
OBSERVATIONAL
2023
IN_VITRO
2019
IN_VITRO
2019
OBSERVATIONAL
2018
IN_VITRO
2018
RCT
2017
IN_VITRO
2016
REVIEW
2015
ANIMAL
2014
META_ANALYSIS
2013
IN_VITRO
2013
RCT
2013
RCT
2012
RCT
2012
OTHER
2012
OTHER
2012
IN_VITRO
2011
ANIMAL
2011
WGS
2011
IN_VITRO
Browse all 102 papers →
Evaluation of the effect of adding probiotic supplementation in patients with chronic spontaneous urticaria
· Dermatologica Sinica
Viability and In Vitro Gastrointestinal Transit Tolerance of Multispecies Probiotic Combinations Incorporated into Orange Juice and Drinking Water
· Foods
Inhibitory effect of probiotic lactobacilli against Streptococcus mutans and Porphyromonas gingivalis biofilms
· Scientific Dental Journal
Microbiota development and mucosal IgA responses during childhood in health and allergic disease
·
Influence of environmental and genetic factors on 3‐hydoxypropionaldehyde production by Lactobacillus reuteri
· Journal of Basic Microbiology
Effect of chewing gums containing probiotics and xylitol on oral health in children: A randomized controlled trial
· Journal of international oral health
Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri
· Folia Microbiologica
INFLUENCE VIOLATIONS FORMATION OF INTESTINAL FLORA, INTESTINAL BARRIER FUNCTION IN NEWBORNS OF INFECTIOUS AND INFLAMMATORY DISEASES AND THE IMPORTANCE OF PROBIOTICS IN THEIR PREVENTION
· Neonatology surgery and perinatal medicine
Early Colonization of Lactobacillus reuteri after Exposure to Probiotics
· Journal of Clinical Pediatric Dentistry
Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children
· Beneficial Microbes
Desarrollo, caracterización y optimización de productos fermentados a base de licuados vegetales como alternativa a los yogures convencionales.
·
No effect of probiotics on respiratory allergies: a seven‐year follow‐up of a randomized controlled trial in infancy
· Pediatric Allergy and Immunology
Oral Administration of Lactobacillus reuteri during the First Year of Life Reduces Caries Prevalence in the Primary Dentition at 9 Years of Age
· Caries Research
Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea ‐ a double‐blind study
· Alimentary Pharmacology & Therapeutics
Development of a potential functional food prepared with pigeon pea (Cajanus cajan), oats and Lactobacillus reuteri ATCC 55730
· International Journal of Food Sciences and Nutrition
Diseño de alimentos potencialmente funcionales sobre la base de productos tradicionales
· Dialnet (Universidad de la Rioja)
Evaluation of the utility of probiotics for the prevention of infections in a model of the skin
· Research Explorer (The University of Manchester)
Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection
· Research in Veterinary Science
Exploring Metabolic Pathway Reconstruction and Genome-Wide Expression Profiling in Lactobacillus reuteri to Define Functional Probiotic Features
· PLoS ONE
The potential of biodetoxification activity as a probiotic property of Lactobacillus reuteri
· International Journal of Food Microbiology
Discussion
Be the first to comment.
Sign in to join the discussion.
No comments yet.
Citations
Selected papers that name this strain.
-
[1]
Source →Microbiota development and mucosal IgA responses during childhood in health and allergic disease· · 2019
-
[2]
Source →Effect of chewing gums containing probiotics and xylitol on oral health in children: A randomized controlled trial· Journal of international oral health · 2018
-
[3]
PMID 24463209 →Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children· Beneficial Microbes · 2014
-
[4]
PMID 23902407 →No effect of probiotics on respiratory allergies: a seven‐year follow‐up of a randomized controlled trial in infancy· Pediatric Allergy and Immunology · 2013
-
[5]
PMID 24296746 →Oral Administration of Lactobacillus reuteri during the First Year of Life Reduces Caries Prevalence in the Primary Dentition at 9 Years of Age· Caries Research · 2013
-
[6]
Source →Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea ‐ a double‐blind study· Alimentary Pharmacology & Therapeutics · 2012
-
[7]
PMID 22150569 →Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis· Alimentary Pharmacology & Therapeutics · 2011
-
[8]
PMID 21552138 →A Randomized, Double-blind, Placebo-controlled Pilot Study of Lactobacillus reuteri ATCC 55730 for the Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults· Journal of Clinical Gastroenterology · 2011
-
[9]
PMID 20639717 →Lactobacillus reuteri Modulates Cytokines Production in Exhaled Breath Condensate of Children With Atopic Dermatitis· Journal of Pediatric Gastroenterology and Nutrition · 2010
-
[10]
PMID 21306085 →Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects.· PubMed · 2010